Literature DB >> 23043248

Estrogen and cancer.

Jing Liang1, Yongfeng Shang.   

Abstract

Estrogen exhibits a broad spectrum of physiological functions ranging from regulation of the menstrual cycle and reproduction to modulation of bone density, brain function, and cholesterol mobilization. Despite the beneficial actions of endogenous estrogen, sustained exposure to exogenous estrogen is a well-established risk factor for various cancers. We summarize our current understanding of the molecular mechanisms of estrogen signaling in normal and cancer cells and discuss the major challenges to existing antiestrogen therapies.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23043248     DOI: 10.1146/annurev-physiol-030212-183708

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  104 in total

1.  Estrogen receptor α promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f).

Authors:  Rafael Cuesta; Adi Y Berman; Anya Alayev; Marina K Holz
Journal:  J Biol Chem       Date:  2018-12-20       Impact factor: 5.157

2.  10β,17α-Dihydroxyestra-1,4-dien-3-one: A Bioprecursor Prodrug Preferentially Producing 17α-Estradiol in the Brain for Targeted Neurotherapy.

Authors:  Katalin Prokai-Tatrai; Vien Nguyen; Laszlo Prokai
Journal:  ACS Chem Neurosci       Date:  2018-06-05       Impact factor: 4.418

Review 3.  Targeted Protein Degradation by Small Molecules.

Authors:  Daniel P Bondeson; Craig M Crews
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016-10-12       Impact factor: 13.820

4.  The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer.

Authors:  Wanjin Li; Zihan Zhang; Xinhua Liu; Xiao Cheng; Yi Zhang; Xiao Han; Yu Zhang; Shumeng Liu; Jianguo Yang; Bosen Xu; Lin He; Luyang Sun; Jing Liang; Yongfeng Shang
Journal:  J Clin Invest       Date:  2017-08-14       Impact factor: 14.808

5.  Estrogen receptor signaling is reprogrammed during breast tumorigenesis.

Authors:  David Chi; Hari Singhal; Lewyn Li; Tengfei Xiao; Weihan Liu; Matthew Pun; Rinath Jeselsohn; Housheng He; Elgene Lim; Raga Vadhi; Prakash Rao; Henry Long; Judy Garber; Myles Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-20       Impact factor: 11.205

6.  In search of novel drug target sites on estrogen receptors using RNA aptamers.

Authors:  Daiying Xu; Vamsee-Krishna Chatakonda; Antonis Kourtidis; Douglas S Conklin; Hua Shi
Journal:  Nucleic Acid Ther       Date:  2014-03-03       Impact factor: 5.486

7.  Juvenile hormone regulates body size and perturbs insulin signaling in Drosophila.

Authors:  Christen Kerry Mirth; Hui Yuan Tang; Sasha C Makohon-Moore; Samy Salhadar; Rewatee H Gokhale; Raechel D Warner; Takashi Koyama; Lynn M Riddiford; Alexander W Shingleton
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

8.  Cryptotanshinone inhibits breast cancer cell growth by suppressing estrogen receptor signaling.

Authors:  Shanhu Li; Hongtao Wang; Liu Hong; Wei Liu; Fang Huang; Jian Wang; Peng Wang; Xiaoqing Zhang; Jianguang Zhou
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 9.  L-Type Calcium Channels Modulation by Estradiol.

Authors:  Nelson E Vega-Vela; Daniel Osorio; Marco Avila-Rodriguez; Janneth Gonzalez; Luis Miguel García-Segura; Valentina Echeverria; George E Barreto
Journal:  Mol Neurobiol       Date:  2016-08-15       Impact factor: 5.590

10.  Endometrial Tumour Microenvironment.

Authors:  Carlos Casas-Arozamena; Miguel Abal
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.